These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 4977072

  • 1. [Effect of intrapulmonary injection of antibody on the formation of pulmonary lesions by intravenous injection of inactivated tubercle bacilli].
    Hatta K.
    Arerugi; 1969 Feb; 18(2):117-20. PubMed ID: 4977072
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of local application of antiserum on the development of tuberculous lesions in the lung of the guinea pig.
    Hatta K.
    Jpn J Tuberc Chest Dis; 1968 Dec; 15(1):10-6. PubMed ID: 5309128
    [No Abstract] [Full Text] [Related]

  • 5. [Forms of the specific immune response in tuberculosis and their relationship to the morphological characteristics of the process].
    Knoring BE, Chuzhova NM, Otten TF, Raskina ES.
    Probl Tuberk; 1980 Apr; (4):47-51. PubMed ID: 6770366
    [No Abstract] [Full Text] [Related]

  • 6. [Studies on the specificity and antigenic composition of fractions from Mycobacterium tuberculosis, bovine type and Mycobacterium fortuitum. 3. Hemagglutination, hemolysis and complement fixation reactions].
    Micke H.
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Aug; 131(2):134-69. PubMed ID: 4231175
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunopathological study of experimental tuberculosis.
    Morikawa K, Okuyama H, Kawachi K, Hamada E.
    Jpn J Tuberc; 1966 Dec; 13():Suppl:27-52. PubMed ID: 4962111
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Humoral immune response in human pulmonary tuberculosis: antibodies against Mycobacterium tuberculosis polysaccharide, protein and glycolipid antigens.
    Stavri D, Niculescu D, Stavri H, Borea F, Stanciu G, Basacopol A.
    Roum Arch Microbiol Immunol; 1993 Dec; 52(2):109-19. PubMed ID: 8186454
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A.
    Sugawara I, Udagawa T, Taniyama T.
    Tuberculosis (Edinb); 2007 Mar; 87(2):94-101. PubMed ID: 16815096
    [Abstract] [Full Text] [Related]

  • 15. Cytotoxic lymphoid cells and antibodies from guinea pigs immunized with tubercle bacilli.
    Wasserman J, Packalén T, Perlmann P, Perlmann H.
    Acta Pathol Microbiol Scand; 1968 Mar; 72(3):453-4. PubMed ID: 4969349
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Progressive pulmonary tuberculosis is not due to increasing numbers of viable bacilli in rabbits, mice and guinea pigs, but is due to a continuous host response to mycobacterial products.
    Dannenberg AM, Collins FM.
    Tuberculosis (Edinb); 2001 Mar; 81(3):229-42. PubMed ID: 11466035
    [Abstract] [Full Text] [Related]

  • 18. [Tuberculosis immunity and allergy].
    Kekkaku; 1968 Mar; 43(3):25-8. PubMed ID: 4971117
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.